PB
PBK
POWERBANK Corp
$0.9030
-3.01%
$42.4M
No data for this timeframe.
Vol
Market Cap$42.4M
Cap SizeNano Cap
Inst. Holders6 funds
Inst. Value$53.5K
Inst. Activity2 buys / 0 sells
Reddit Sentiment67° Warm
Recent Activity
Inst.
NATIONAL BANK OF CANADA — DOUBLED
9,927 shares ($4.8K)
Inst.
TD Waterhouse Canada Inc. — ADD
147 shares ($70.00)
Price Targets
No recent covering-analyst activity on file. No current recommendation available.
$4.00
Current $0.9025
Low $2.00
Median $4.00
High $6.00
2 analysts
$2.00
$6.00
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.00 ▼ -104.4% | $-0.01 — $0.00 | 99% YoY | 2 |
| Next Q | $-0.01 | $-0.01 — $-0.01 | -205% YoY | 1 |
| Current FY | $-0.23 ▼ -435.3% | $-0.23 — $-0.23 | 67% YoY | 2 |
| Next FY | $0.03 ▼ -61.0% | $-0.01 — $0.08 | 114% YoY | 2 |
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| CITADEL ADVISORS LLC | $47.5K | — |
| NATIONAL BANK OF CANADA | $4.8K | DOUBLED |
| ROYAL BANK OF CANADA | $1.0K | — |
| WELLS FARGO & COMPANY/MN | $134.00 | — |
| TD Waterhouse Canada Inc. | $70.00 | ADD |
Reddit Sentiment
67°
Warm
Bearish
Neutral
Bullish
6 institutional holders with $53.5K total value (101,455 shares) as of 2026-Q1. Top holders: CITADEL, NATIONAL, ROYAL. Net buying activity: 2 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | 88,674 | $47.5K | 88.7% | — |
| 2 | NATIONAL BANK OF CANADA /FI/ | 9,927 | $4.8K | 9.0% | DOUBLED +624.1% |
| 3 | ROYAL BANK OF CANADA | 2,377 | $1.0K | 1.9% | — |
| 4 | WELLS FARGO & COMPANY/MN | 250 | $134.00 | 0.3% | — |
| 5 | TD Waterhouse Canada Inc. | 147 | $70.00 | 0.1% | ADD +50.0% |
| 6 | MORGAN STANLEY | 80 | $43.00 | 0.1% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| NATIONAL BANK OF CANADA /FI/ | DOUBLED | 1,371 | 9,927 | +624.1% | $4.8K | 2026-Q1 |
| TD Waterhouse Canada Inc. | ADD | 98 | 147 | +50.0% | $70.00 | 2026-Q1 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Analyst Price Targets
No recent covering-analyst activity on file. No current recommendation available.
$4.00 mean target
$2.00 Low
$6.00 High
| Metric | Value |
|---|---|
| Current Price | $0.9025 |
| Target Low | $2.00 |
| Target Mean | $4.00 |
| Target Median | $4.00 |
| Target High | $6.00 |
| # Analysts | 2 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.00 | $-0.01 | $0.00 | 99.3% | -104.4% | — | $0.0B | 15.1% | 2 |
| Next Q 2026-09-30 |
$-0.01 | $-0.01 | $-0.01 | -205.1% | — | — | $0.0B | -37.0% | 1 |
| Current FY 2026-06-30 |
$-0.23 | $-0.23 | $-0.23 | 67.2% | -435.3% | 0↑ 1↓ | $0.0B | -12.0% | 2 |
| Next FY 2027-06-30 |
$0.03 | $-0.01 | $0.08 | 114.0% | -61.0% | 0↑ 1↓ | $0.1B | 103.6% | 2 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.004 | |
| 7d ago | $0.000 | -0.004 |
| 30d ago | $0.080 | -0.084 |
| 60d ago | $0.080 | -0.084 |
| 90d ago | $0.080 | -0.084 |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
67°
Warm
Bearish
Neutral
Bullish
2 mentions
2 bullish
0 bearish
2 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Jun 12, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Jun 12, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
Recent Reddit Threads
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.